Enochian Biosciences Inc (ENOB)

NASDAQ
8.980
+0.040(+0.45%)
After Hours
8.980
0.000(0.00%)
- Real-time Data
  • Volume:
    129,286
  • Bid/Ask:
    8.200/9.200
  • Day's Range:
    8.830 - 9.150

ENOB Overview

Prev. Close
8.94
Day's Range
8.83-9.15
Revenue
-
Open
8.98
52 wk Range
2.6-12.89
EPS
-0.56
Volume
129,286
Market Cap
468.93M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
255,743
P/E Ratio
-
Beta
0.54
1-Year Change
168.86%
Shares Outstanding
52,219,661
Next Earnings Date
-
What is your sentiment on Enochian Biosciences Inc?
or
Market is currently closed. Voting is open during market hours.

Enochian Biosciences Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyBuySellStrong BuyStrong Buy
SummaryStrong BuyStrong BuyNeutralStrong BuyStrong Buy

Enochian Biosciences Inc Company Profile

Enochian Biosciences Inc Company Profile

Employees
11

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company’s lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California.

Read More
  • J&J just announced they failed trials for HIV vaccine.
    0
    • Everyone is buying and holding. NoSelling!!! Pay-tience will get rewarded
      0
      • Strong pre market and now red. Makes no sense.
        0
        • https://finance.yahoo.com/news/enochian-biosciences-announces-acquisition-exclusive-110000233.html
          0
          • What's the news? Pump and dump week?
            0
            • Pump and dump is over, time to go up again if it sustains above $6
              0
              • What happened guys? I am down by a lot
                0
                • should I buy in this stock? any forecast?
                  0
                  • kinda curios why this isn't on wealth simple?
                    0
                    • kinda curios why this isn't on wealth simple?
                      0
                      • TAK FDA approval decision tommororw. go big or go home
                        1
                        • Maybe it was a pump and dump
                          0
                          • back to 4 dollars
                            0
                            • People are really selling now
                              0
                              • What happened
                                0
                                • To 9.2
                                  0
                                  • It will go to 25$
                                    0
                                    • $20
                                      0
                                      • Well, people are selling like hot cakes so doesn't seem plausible
                                        0
                                    • How high can this go guys?
                                      0
                                      • promising signs of control of HIV on a 54 years old man for 200days ...haha... the world needs a drug for this HIV so blatant
                                        0
                                        • What are you talking about? Bit touched arent you?
                                          0
                                      • FDA accepted a Pre-IND (Investigational New Drug) request for a potential functional cure or treatment of HIV.
                                        0
                                        • What's the news?
                                          0
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.